{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P02768",
      "entity_text" : "serum albumin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:126941",
      "entity_text" : "methotrexate",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0564" ],
      "Organ" : [ "uberon:UBERON:0006611" ]
    }
  },
  "verbose_text" : "Another clinically relevant issue is potential interactions between methotrexate and other drugs, including drugs that may decrease methotrexate binding to serum albumin; probenecid, which may inhibit tubular secretion; drugs with known kidney or liver toxicity; and alcohol.",
  "reading_complete" : "2020-08-04T14:45:02Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:26:29Z",
  "trigger" : "binding",
  "evidence" : [ "methotrexate binding to serum albumin" ],
  "pmc_id" : "7367959",
  "score" : 0
}